|
|
||||||||
J Thorac Cardiovasc Surg 2004;128:327-328
© 2004 The American Association for Thoracic Surgery
Letter to the editor |
a Cattedra di Cardiochirurgia, Università degli Studi di Milano, Policlinico MultiMedica, Milan, Italy
| The first 20% of the full text of this article appears below. |
To the Editor:
We congratulate Dr Medalion and coworkers1 for the results reported in their study recently published in the Journal that focused on the effects of enoxaparin in patients undergoing coronary operations. The optimal administration of low-molecular-weight heparin in cardiac surgery is a controversial issue.2,3 The use of enoxaparin in patients with prosthetic valves has also been recently described.4,5 Because we have routinely used enoxaparin both preoperatively and postoperatively in nonemergency cardiac patients at our institution during the last 5 years, we would like to outline some aspects of our experience.
When we started using enoxaparin in 1998, we had some concerns related to
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |